98 related articles for article (PubMed ID: 8102889)
1. Adrenocortical carcinoma--diagnostic and therapeutical implications.
Ahlman H; Jansson S; Wängberg B; Tisell LE; Scherstén T; Hansson G; Bengtsson BA; Ernest I; Jakobsson CE; Lindstedt S
Eur J Surg; 1993 Mar; 159(3):149-58. PubMed ID: 8102889
[TBL] [Abstract][Full Text] [Related]
2. [Surgical strategy in the treatment of adrenal cortex cancer. Expanded and repeated interventions].
Borrelli D; Bergamini C; Borrelli A; Reddavide S; Lassig R; Valeri A
Ann Ital Chir; 2003; 74(3):311-7. PubMed ID: 14677288
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
4. Adrenocortical carcinoma: retrospective study of 14 patients experienced at a single institution over 34 years.
Nishida S; Itoh N; Sasao T; Masumori N; Taguchi K; Tsukamoto T
Int J Urol; 2007 Jul; 14(7):581-4. PubMed ID: 17645596
[TBL] [Abstract][Full Text] [Related]
5. A case of recurrent adrenocortical carcinoma, with observations on long-term o,p'-DDD therapy and complications.
van Aalderen W; van Seters AP; Backer ET; Chang PC; van Krieken JH; Moolenaar AJ
Neth J Med; 1992 Oct; 41(3-4):161-70. PubMed ID: 1470288
[TBL] [Abstract][Full Text] [Related]
6. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
7. The surgical management of adrenal cortical carcinoma.
Linos DA; Vassilopoulos PP; Papadimitriou J; Tountas K
Int Surg; 1986; 71(2):104-6. PubMed ID: 3733353
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
10. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma.
Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070
[TBL] [Abstract][Full Text] [Related]
11. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up.
Kasperlik-Zaluska AA; Cichocki A
J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038
[TBL] [Abstract][Full Text] [Related]
12. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
13. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors.
To EW; Lai EC; Cheng JH; Pang PC; Williams MD; Teo PM
Laryngoscope; 2002 Oct; 112(10):1877-82. PubMed ID: 12368634
[TBL] [Abstract][Full Text] [Related]
15. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
16. [Carcinoma of the adrenal cortex].
Hamborg B; Frey H; Bøhmer T; Norman N
Tidsskr Nor Laegeforen; 1990 Mar; 110(8):956-9. PubMed ID: 2321225
[TBL] [Abstract][Full Text] [Related]
17. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
18. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
20. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.
Sandhu SS; Symes A; A'Hern R; Sohaib SA; Eisen T; Gore M; Christmas TJ
BJU Int; 2005 Mar; 95(4):522-5. PubMed ID: 15705072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
